Search Results - "Scott, Lesley"
-
1
Givosiran: First Approval
Published in Drugs (New York, N.Y.) (01-02-2020)“…Givosiran (Givlaari™) is an aminolevulinate synthase 1 (ALAS1)-directed small interfering RNA (siRNA) covalently linked to a ligand to enable specific delivery…”
Get full text
Journal Article -
2
Tocilizumab: A Review in Rheumatoid Arthritis
Published in Drugs (New York, N.Y.) (01-11-2017)“…Intravenous (IV) and subcutaneous (SC) tocilizumab (RoActemra ® ), an IL-6 receptor antagonist, are approved (± methotrexate) in numerous countries throughout…”
Get full text
Journal Article -
3
Niraparib: First Global Approval
Published in Drugs (New York, N.Y.) (01-06-2017)“…Oral niraparib, a highly-selective, potent poly(ADP-ribose) polymerase (PARP)-1 and PARP-2 inhibitor, is approved in the USA for the maintenance treatment of…”
Get full text
Journal Article -
4
Larotrectinib: First Global Approval
Published in Drugs (New York, N.Y.) (01-02-2019)“…Larotrectinib (VITRAKVI ® ) is an orally administered, small molecule, highly-selective, tropomyosin receptor kinase (TRK) inhibitor that was developed by Loxo…”
Get full text
Journal Article -
5
Apatinib: A Review in Advanced Gastric Cancer and Other Advanced Cancers
Published in Drugs (New York, N.Y.) (01-05-2018)“…Apatinib [Aitan ® (brand name in China)], also known as rivoceranib, is a novel, small molecule, selective vascular endothelial growth factor receptor-2…”
Get full text
Journal Article -
6
Ubrogepant: First Approval
Published in Drugs (New York, N.Y.) (01-02-2020)“…Ubrogepant (Ubrelvy™) is an orally administered, small molecule, highly-selective, calcitonin gene-related peptide (CGRP) antagonist that was developed by…”
Get full text
Journal Article -
7
Eravacycline: A Review in Complicated Intra-Abdominal Infections
Published in Drugs (New York, N.Y.) (01-02-2019)“…Eravacycline (Xerava™), a novel fully synthetic fluorocycline, consists of the tetracyclic core scaffold with unique modifications in the tetracyclic D ring;…”
Get full text
Journal Article -
8
Sitagliptin: A Review in Type 2 Diabetes
Published in Drugs (New York, N.Y.) (01-02-2017)“…The dipeptidyl peptidase-4 inhibitor sitagliptin (Januvia ® ; Glactiv ® ; Tesavel ® ; Xelevia™) is approved in more than 130 countries worldwide as monotherapy…”
Get full text
Journal Article -
9
Lemborexant: First Approval
Published in Drugs (New York, N.Y.) (01-03-2020)“…Lemborexant (DAYVIGO™) is an orally administered, dual orexin receptor (OXR) antagonist that exhibits reversible competitive antagonism at OXR1 and OXR2 (>…”
Get full text
Journal Article -
10
Rimegepant: First Approval
Published in Drugs (New York, N.Y.) (01-05-2020)“…The orally disintegrating tablet (ODT) formulation of rimegepant (NURTEC ODT ® ) is a small molecule, highly-selective, calcitonin gene-related peptide…”
Get full text
Journal Article -
11
Enzalutamide: A Review in Castration-Resistant Prostate Cancer
Published in Drugs (New York, N.Y.) (01-12-2018)“…Oral enzalutamide (Xtandi ® ), a second generation androgen receptor inhibitor, is indicated for the treatment of castration-resistant prostate cancer (CRPC)…”
Get full text
Journal Article -
12
Siponimod: A Review in Secondary Progressive Multiple Sclerosis
Published in CNS drugs (01-11-2020)“…Oral siponimod (Mayzent ® ), a next-generation, selective sphingosine 1-phosphate receptor (S1PR) 1 and 5 modulator, is approved in several countries for the…”
Get full text
Journal Article -
13
Lumasiran: First Approval
Published in Drugs (New York, N.Y.) (01-02-2021)“…Lumasiran (Oxlumo™) is a subcutaneously administered small interfering RNA (siRNA) targeting the mRNA for hydroxyacid oxidase 1 gene ( HAO1 ; encodes glycolate…”
Get full text
Journal Article -
14
Alipogene Tiparvovec: A Review of Its Use in Adults with Familial Lipoprotein Lipase Deficiency
Published in Drugs (New York, N.Y.) (01-02-2015)“…Alipogene tiparvovec (Glybera ® ; AMT-011, AAV1-LPL S447X ) is an adeno-associated virus serotype 1-based gene therapy for adult patients with familial…”
Get full text
Journal Article -
15
Brexanolone: First Global Approval
Published in Drugs (New York, N.Y.) (01-05-2019)“…Brexanolone (ZULRESSO™) is an intravenously administered, small molecule, neuroactive steroid GABA A receptor positive allosteric modulator that was developed…”
Get full text
Journal Article -
16
Ferric Carboxymaltose: A Review in Iron Deficiency
Published in Drugs (New York, N.Y.) (01-03-2018)“…Intravenous ferric carboxymaltose (Ferinject ® ; Injectafer ® ) is a colloidal solution of nanoparticles which consist of a polynuclear iron…”
Get full text
Journal Article -
17
Dulaglutide: A Review in Type 2 Diabetes
Published in Drugs (New York, N.Y.) (01-02-2020)“…Subcutaneous dulaglutide (Trulicity ® ) is a once-weekly glucagon-like peptide-1 receptor agonist that is approved in numerous countries as an adjunct to diet…”
Get full text
Journal Article -
18
Dolutegravir/Lamivudine Single-Tablet Regimen: A Review in HIV-1 Infection
Published in Drugs (New York, N.Y.) (2020)“…The oral once-daily, fixed-dose single-tablet regimen (STR) of dolutegravir/lamivudine (Dovato ® ), combining a second generation integrase single-strand…”
Get full text
Journal Article -
19
Teriflunomide: A Review in Relapsing–Remitting Multiple Sclerosis
Published in Drugs (New York, N.Y.) (01-06-2019)“…Teriflunomide (Aubagio ® ) is a disease-modifying immunomodulatory drug with anti-inflammatory properties that selectively and reversibly inhibits the…”
Get full text
Journal Article -
20
Peramivir: A Review in Uncomplicated Influenza
Published in Drugs (New York, N.Y.) (01-09-2018)“…Intravenous peramivir (Alpivab™; Rapivab ® ; Rapiacta ® ; PeramiFlu ® ), the most recent globally approved inhibitor of influenza neuraminidase, is indicated…”
Get full text
Journal Article